Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Leuprorelin, Atc L02ae02 for the Period December 1St, 2023 - November 30Th, 2024 (Plus Extension Option 1X12 Months)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate, Atc J05ar24 for the Period December 1St, 2023 - November 30Th, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Distigmin, Atc N07aa03 for the Period December 1St, 2023 - November 30Th, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Clobetasol, Atc D07ad01 for the Period December 1St, 2023 - November 30Th, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Tocilizumab, Atc L04ac07 for the Period December 1St, 2023 - November 30Th, 2024 (Plus Extension Option 1X12 Months)

Laparoscopy and Thoracoscopy Accessories Dps

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Sumatriptan (Excluding Film-Coated Tablets and Tablets), Atc N02cc01 for the Period December 1St, 2023 - November 30Th, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Doravirine, Atc J05ag06 for the Period December 1St, 2023 - November 30Th, 2025

Open House Drug Discount Agreements Pegfilgrastim, Atc L03aa13

Patient Monitoring System